Gelsoft Vascular Graft
PMA P890045
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA PMAAPRL | NumberP890045 | Date11 Jan 1993 | StatusActive |
Recalls
-
- Terminated Z-1912-2015
- Terminated Z-1913-2015
Product was labeled as a 30cm graft, when in fact the graft in the box was a 15cm graft.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Full name
- Vascutek Gelsoft(Tm) Vascular Graft
- Trade Name
- Gelseal Tm Triaxial Vascular Graft
- Generic Name
- GRAFT, VASCULAR, SYNTHETIC/BIOLOGIC COMPOSITE
- PMA Number
- FDA Product Code
- MAL
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.3450
- Advisory Committee
- Cardiovascular
- FDA Decision
- APRL
Overview
AI-generated summary, 18 Sep 2026
The Gelsoft Vascular Graft is a synthetic/biologic composite vascular graft, designed as a replacement or bypass conduit for cardiovascular applications. It is classified as a Class II medical device under the FDA’s regulatory framework, intended for use in surgical procedures requiring durable vascular support.
This graft is supplied sterile and intended for single-use. It is manufactured in various sizes and configurations, as indicated by the registration numbers, and must be stored under appropriate conditions to maintain sterility. The device holds an FDA Premarket Approval (PMA) under PMA number P890045, with regulatory oversight under 21 CFR 870.3450 for vascular grafts.
Other devices from Carbomedics, Inc.
Questions
AI-generated answers, 18 Sep 2026
What types of cardiovascular procedures is the Gelsoft Vascular Graft intended to support as a replacement or bypass conduit?
The Gelsoft Vascular Graft is designed specifically for surgical procedures requiring durable vascular support, such as arterial bypasses or replacements in cardiovascular applications. Its synthetic/biologic composite construction makes it suitable for use in contexts where long-term patency and structural integrity are critical, such as coronary, peripheral, or other vascular reconstructions.
Is the Gelsoft Vascular Graft reusable, or is it meant for single-use only? How should it be stored to maintain sterility?
The Gelsoft Vascular Graft is explicitly intended for single-use only and is supplied sterile. To preserve sterility, it must be stored under appropriate conditions as specified by the manufacturer, typically in a sealed, sterile packaging until the time of use. Improper storage could compromise its integrity.
What sizes or configurations are available for the Gelsoft Vascular Graft, and how can I identify them?
The Gelsoft Vascular Graft is manufactured in multiple sizes and configurations, each corresponding to specific registration numbers (e.g., 2246552, 9612515, 1640201, etc.). These identifiers help distinguish between diameters, lengths, or other variations. The exact sizing details should be referenced in the manufacturer’s documentation or catalog, as they are tailored to different surgical needs.
How was the regulatory approval process for the Gelsoft Vascular Graft structured, and what does the PMA number indicate?
The Gelsoft Vascular Graft received FDA Premarket Approval (PMA) under PMA number P890045, which means it underwent a rigorous review process to ensure safety and effectiveness. The PMA was granted after submission to the FDA’s Cardiovascular (CV) Advisory Committee in 1989, with a final decision in 1993. This approval pathway is required for Class II devices like vascular grafts, ensuring compliance with 21 CFR 870.3450.